Colorectal cancer (CRC) disproportionately affects Hispanic/Latino (H/L) populations, yet little is known about survival outcomes across dual-treatment regimens in diverse populations. The study aims to identify differences in molecular pathway alterations between H/L and non-Hispanic White (NHW) patients and to...
Victor E. Morales, E. Villarreal· Cancer Epidemiology, Biomark...· 0 citations
Colorectal cancer (CRC) is the second leading cause of cancer deaths worldwide, disproportionately affecting Hispanic/Latino (H/L) patients due to a combination of genetic and environmental factors. Several treatment regimens are used for CRC, but it remains unclear whether molecular pathway alterations are assoc...
E. Villarreal, Victor E. Morales· Cancer Epidemiology, Biomark...· 0 citations
Pancreatic ductal adenocarcinoma (PDAC) is characterized by extensive molecular heterogeneity, complex pathway interactions, stromal remodeling, and variable responses to systemic therapy. Although KRAS and TP53 represent major genomic drivers, the broader signaling architecture underlying age- and treatment-spec...
E. Villarreal· Cancer Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.